References
- Sharif MR, Nouri S. Clinical signs and symptoms and laboratory findings of methadone poisoning in children. Iran J Pediatr. 2015;25(1):e176.
- Hassanian-Moghaddam H, Hakiminejhad M, Farnaghi F, et al. Eleven years of children methadone poisoning in a referral center: a review of 453 cases. J Opioid Manag. 2017;13(1):27–36.
- Watson WA, Litovitz TL, Rodgers GJ, et al. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23(5):589–666.
- Alotaibi N, Sammons H, Choonara I. Methadone toxicity in children. Arch Dis Child. 2012;97(5):e1.
- Schwartz L, Mercurio-Zappala M, Howland MA, et al. Unintentional methadone and buprenorphine exposures in children: developing prevention messages. J Am Pharm Assoc. 2017;57(2S):S83–S86.
- Budnitz DS, Lovegrove MC, Sapiano MR, et al. Notes from the field: pediatric emergency department visits for buprenorphine/naloxone ingestion – United States, 2008-2015. MMWR Morb Mortal Wkly Rep. 2016;65(41):1148–1149.
- Kliegman R, Behrman RE, Geme JWS, et al. Nelson textbook of pediatrics. Amsterdam (The Netherlands): Elsevier, 2020. p. 478.
- Bernstein D, Shelov SP. Pediatrics for medical students. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2011.
- Kliegman R, Behrman RE, Geme JWS, et al. Nelson textbook of pediatrics. Amsterdam (The Netherlands): Elsevier, 2020. p. 491.
- Hamdi H, Hassanian-Moghaddam H, Hamdi A, et al. Acid-base disturbances in acute poisoning and their association with survival. J Crit Care. 2016;35:84–89.
- Pearce N. Analysis of matched case-control studies. BMJ. 2016;352:969.
- Boyer EW, McCance-Katz EF, Marcus S. Methadone and buprenorphine toxicity in children. Am J Addict. 2010;19(1):89–95.
- von Fabeck K, Boulamery A, Glaizal M, et al. Buprenorphine poisoning in children: a 10-year-experience of Marseille Poison Center. Fundam Clin Pharmacol. 2020;34(2):265–269.
- Shulman M, Wai JM, Nunes EV. Buprenorphine treatment for opioid use disorder: an overview. CNS Drugs. 2019;33(6):567–580.
- Kelty E, Hulse G, Joyce D, et al. Impact of pharmacological treatments for opioid use disorder on mortality. CNS Drugs. 2020;34(6):629–642.
- Sarton E, Teppema L, Dahan A. Naloxone reversal of opioid induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine. Ad Exp Med Biol. 2008;605:486–491.
- Geib AJ, Babu K, Ewald MB, et al. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics. 2006;118(4):1746–1751.
- Martin TC, Rocque MA. Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999-2009. CDS. 2011;6(1):12–16.
- Shadnia S, Rahimi M, Hassanian-Moghaddam H, et al. Methadone toxicity: comparing tablet and syrup formulations during a decade in an academic poison center of Iran. Clinical Toxicology. 2013;51(8):777–782.